Terms: = Bone cancer AND HOXD13, SPD, 3239, P35453, HOX4I AND Treatment
10 results:
1. Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice.
An W; Feola M; Levy M; Aluri S; Ruiz-Martinez M; Sridharan A; Fibach E; Zhu X; Verma A; Ginzburg Y
Elife; 2023 Dec; 12():. PubMed ID: 38153418
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.
Schuler A; Huser J; Schmid S; Schär S; Scherz A; Gautschi O; Mauti L; von Briel T; Waibel C; Wannesson L; Pankovics J; Mark MT; Rothschild SI; Addeo A; Janthur WD; Siano M; Boos L; Britschgi C; Früh M
Lung Cancer; 2024 Jan; 187():107427. PubMed ID: 38043395
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma.
Soydal C; Nak D; Araz M; Akkus P; Urun Y; Ozkan E; Kucuk NO; Kir MK
Nucl Med Commun; 2019 Dec; 40(12):1243-1249. PubMed ID: 31688499
[TBL] [Abstract] [Full Text] [Related]
4. Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients.
El-Ghammaz AMS; Gadallah HA; Kamal G; Maher MM; Mohamad MA
Clin Exp Med; 2018 Nov; 18(4):505-512. PubMed ID: 29876769
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.
Bhagat TD; Chen S; Bartenstein M; Barlowe AT; Von Ahrens D; Choudhary GS; Tivnan P; Amin E; Marcondes AM; Sanders MA; Hoogenboezem RM; Kambhampati S; Ramachandra N; Mantzaris I; Sukrithan V; Laurence R; Lopez R; Bhagat P; Giricz O; Sohal D; Wickrema A; Yeung C; Gritsman K; Aplan P; Hochedlinger K; Yu Y; Pradhan K; Zhang J; Greally JM; Mukherjee S; Pellagatti A; Boultwood J; Will B; Steidl U; Raaijmakers MHGP; Deeg HJ; Kharas MG; Verma A
Cancer Res; 2017 Sep; 77(18):4846-4857. PubMed ID: 28684528
[TBL] [Abstract] [Full Text] [Related]
6. Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions.
Richardson K; Potter M; Damron TA
J Surg Oncol; 2016 Jun; 113(7):818-22. PubMed ID: 27060189
[TBL] [Abstract] [Full Text] [Related]
7. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract] [Full Text] [Related]
8. Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-hoxd13-driven mouse model.
Xu H; Menendez S; Schlegelberger B; Bae N; Aplan PD; Göhring G; Deblasio TR; Nimer SD
Blood; 2012 Oct; 120(15):3089-97. PubMed ID: 22927245
[TBL] [Abstract] [Full Text] [Related]
9. A dose-finding study of zoledronate in hypercalcemic cancer patients.
Body JJ; Lortholary A; Romieu G; Vigneron AM; Ford J
J Bone Miner Res; 1999 Sep; 14(9):1557-61. PubMed ID: 10469284
[TBL] [Abstract] [Full Text] [Related]
10. Significance of tubal resection in surgical treatment of middle ear carcinoma.
Mohri M; Nagashima T; Tahara S; Amatsu M
Eur Arch Otorhinolaryngol; 1997; 254(4):208-11. PubMed ID: 9151022
[TBL] [Abstract] [Full Text] [Related]
